Spironolactone for all hypertensive patients?

被引：1
|
作者：
Rosendorff, Clive [1 ,2 ]
机构：
[1] James J Peters VA Med Ctr, Bronx, NY 10468 USA
[2] Mt Sinai Sch Med, Dept Med, New York, NY USA
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷 / 01期
关键词：
SELECTIVE ALDOSTERONE BLOCKER; BLOOD-PRESSURE; EPLERENONE;
D O I：
10.1097/HJH.0b013e328334262f
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [41] Should all Hypertensive Patients be Screened for Primary Aldosteronism?
    Alkagiet, Stelina
    Tziomalos, Konstantinos
    CURRENT HYPERTENSION REVIEWS, 2019, 15 (01) : 54 - 56
  • [42] Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?
    Bomback, Andrew S.
    Kshirsagar, Abhijit V.
    Klemmer, Philip J.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2009, 5 (02): : 74 - 75
  • [43] Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?
    Andrew S Bomback
    Abhijit V Kshirsagar
    Philip J Klemmer
    Nature Clinical Practice Nephrology, 2009, 5 : 74 - 75
  • [44] Spironolactone (when all else fails) in hypertension
    Arroll, Bruce
    JOURNAL OF PRIMARY HEALTH CARE, 2010, 2 (04) : 336 - 336
  • [45] Spironolactone Improves Exercise Blood Pressure but Not Functional or Myocardial Parameters in Untreated Patients With a Hypertensive Response to Exercise
    Hare, James L.
    Sharman, James E.
    Leano, Rodel
    Jenkins, Carly
    Wright, Leah
    Marwick, Thomas H.
    CIRCULATION, 2009, 120 (18) : S364 - S364
  • [46] EXCHANGEABLE SODIUM, PLASMA-VOLUME, AND EFFECTS OF SPIRONOLACTONE IN HYPERTENSIVE PATIENTS WITH SUPPRESSED PLASMA-RENIN
    DISTLER, A
    KEIM, HJ
    PHILIPP, T
    PHILIPPI, A
    WALTER, U
    WOLFF, HP
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1973, 3 (03) : 224 - 224
  • [47] Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients
    Song, Shuaiwei
    Cai, Xintian
    Hu, Junli
    Zhu, Qing
    Shen, Di
    Ma, Huimin
    Zhang, Yingying
    Ma, Rui
    Yang, Wenbo
    Hong, Jing
    Zhang, Delian
    Li, Nanfang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2215 - 2225
  • [48] COMPARISON OF POTASSIUM-RETAINING EFFECTS OF AMILORIDE AND SPIRONOLACTONE IN HYPERTENSIVE PATIENTS WITH THIAZIDE-INDUCED HYPOKALEMIA
    GEORGE, CF
    BRECKENRIDGE, AM
    DOLLERY, CT
    LANCET, 1973, 2 (7841): : 1288 - 1291
  • [49] Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity and insulin resistance in hypertensive patients
    Vongpatanasin, Wanpen
    Menon, Dileep V.
    Arbique, Debbie
    Wang, Zhongyun
    Auchus, Richard J.
    HYPERTENSION, 2008, 52 (04) : E43 - E43
  • [50] Effects of combining an angiotensin-II receptor blocker and spironolactone on left ventricular remodeling in hypertensive patients
    Taniguchi, I
    Hashizume, Y
    Yamada, T
    Arino, T
    Kanae, K
    Shimizu, M
    Mochizuki, S
    CIRCULATION, 2003, 107 (19) : E164 - E164
12345